|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2009-10-1
|
|
pubmed:abstractText |
A genome-wide association study has identified the R92Q variant of the TNFRSF1A gene as a new susceptibility locus for multiple sclerosis. This locus is of special interest because the R92Q substitution was previously detected in a group of multiple sclerosis patients who had additional symptoms compatible with the autoinflammatory syndrome TRAPS.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1759-4766
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
528-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19794511-Autoimmune Diseases,
pubmed-meshheading:19794511-Genetic Predisposition to Disease,
pubmed-meshheading:19794511-Genome-Wide Association Study,
pubmed-meshheading:19794511-Humans,
pubmed-meshheading:19794511-Multiple Sclerosis,
pubmed-meshheading:19794511-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:19794511-Receptors, Tumor Necrosis Factor, Type I,
pubmed-meshheading:19794511-Signal Transduction,
pubmed-meshheading:19794511-Syndrome,
pubmed-meshheading:19794511-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Multiple sclerosis. TNFRSF1A, TRAPS and multiple sclerosis.
|
|
pubmed:affiliation |
Institute of Clinical Neuroimmunology-Campus Grosshadern, Ludwig Maximilians University of Munich, Marchioninistrasse 15, Munich, Germany. tania.kuempfel@med.uni-muenchen.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
